SELECT TOP (1000) [Source] ,[Taxon] ,[LowValue] ,[HighValue] ,[LowPCile] ,[HighPCile] FROM [DB_A5D9F7_Lassesen].[dbo].[JasonH]

Amoebophilaceae Details: NCBI 1501348, gram-negative or unknown [family]

| "Amoebophilaceae" Santos-Garcia et al. 2014| Amoebophilaceae

  1. Fermentation and SCFA Production:

    • Oscillibacter, like other members of the Ruminococcaceae family, is involved in the fermentation of dietary fibers and complex carbohydrates in the gut. This fermentation process can lead to the production of short-chain fatty acids (SCFAs) such as acetate, propionate, and butyrate. SCFAs play important roles in maintaining gut health, providing an energy source for colonocytes, and influencing various physiological processes.
  2. Butyrate Production:

    • Oscillibacter has been associated with the production of butyrate, a short-chain fatty acid that has been linked to several health benefits. Butyrate is known for its anti-inflammatory properties and its role in promoting the health of the intestinal lining.
  3. Potential Influence on Metabolic Health:

    • Some studies have suggested that the abundance of Oscillibacter may be associated with certain metabolic parameters. However, the specific mechanisms and associations are still an active area of research, and more studies are needed to elucidate the relationship between Oscillibacter and metabolic health.

A lot more information is available when you are logged in and raise the display level

Other Sources for more information:

More Information
Statistics NCBI Data Punk End Products Produced

Lab Reporting

Different labs use different software to read the sample. See this post for more details.
One lab may say you have none, another may say you have a lot! - This may be solely due to the software they are using to estimate.
We deem lab specific values using values from the KM method for each specific lab to be the most reliable.

Desired Levels Suggestions for Amoebophilaceae

These are values that are computed from lab specific samples (Patent Pending)
LabFrequencyUD-LowUD-HighKM LowKM HighLab LowLab HighMean MedianStandard DeviationBox Plot LowBox Plot High KM Percentile Low KM Percentile High
Other Labs 0.35 3 43 2 50 26.4 30 12.2 3 43 10 %ile 80 %ile
biomesight 84.74 0 170 20 210 0 468 145.8 100 164.2 20 260 4.6 %ile 91 %ile
thorne 55.17 1 52 0 50 12.8 2 18.8 1 52 0 %ile 100 %ile
thryve 0.18 30 110 0 181 70 70 56.6 30 110 25 %ile 50 %ile

External Reference Ranges for Amoebophilaceae

Amoebophilaceae (NCBI 1501348) per million
Source of Ranges Low Boundary High Boundary Low Boundary %age High Boundary %age
Statistic by Lab Source for Amoebophilaceae
These desired values are reported from the lab reports
Lab Frequency Seen Average Standard Deviation Sample Count Lab Samples
BiomeSight 91.83 %   0.015 %  0.017 % 2630.0 2864
CerbaLab 33.333 %   0 %  % 1.0 3
custom 1.695 %   0.003 %  % 1.0 59
es-xenogene 3.448 %   0.003 %  % 1.0 29
Medivere 71.429 %   0.003 %  0.001 % 5.0 7
Thorne 34.444 %   0.001 %  0.001 % 31.0 90
Thryve 0.217 %   0.009 %  0.005 % 3.0 1383

Symptoms Associated with Amoebophilaceae From Citizen Science Studies

Click on Impact for information if high or low levels are causing the impact

MagnitudeImpactSymptom

To see medical conditions associated you may be logged in

And display level must be raised above public.


This is an Academic site. It generates theoretical models of what may benefit a specific microbiome results.

Copyright 2016-2024 Lassesen Consulting, LLC [2007], DBA, Microbiome Prescription. All rights served.
Permission to data scrap or reverse engineer is explicitly denied to all users. U.S. Code Title 18 PART I CHAPTER 47 Β§β€―1030, CETS No.185, CFAA
Use of data on this site is prohibited except under written license. There is no charge for individual personal use. Use for any commercial applications or research requires a written license.
Caveat emptor: Analysis and suggestions are based on modelling (and thus infererence) based on studies. The data sources are usually given for those that wish to consider alternative inferences. theories and models.
Inventions/Methodologies on this site are Patent Pending.

Microbiome Prescription do not make any representations that data or analyses available on this site is suitable for human diagnostic purposes, for informing treatment decisions, or for any other purposes and accept no responsibility or liability whatsoever for such use.
This site is not Health Insurance Portability and Accountability Act of 1996 (HIPAA) compliant.


The awesome web hosting site that we use. Try it if you need to host (or unhappy with current provider)